pandion
therapeutics
participate
panel
discussion
stifel
immunology
inflammation
virtual
summit
watertown
globe
newswire
pandion
therapeutics
nasdaq
pand
biotechnology
company
developing
novel
therapeutics
designed
address
unmet
needs
patients
living
autoimmune
diseases
today
announced
rahul
kakkar
chief
executive
officer
pandion
therapeutics
participate
panel
discussion
upcoming
stifel
immunology
inflammation
summit
thursday
october
et
live
audio
webcast
panel
available
investors
news
section
pandion
therapeutics
investor
website
https
replay
webcast
available
shortly
following
presentation
pandion
therapeutics
pandion
therapeutics
developing
novel
therapeutics
designed
address
unmet
needs
patients
living
autoimmune
diseases
pandion
talon
therapeutic
autoimmune
regulatory
protein
drug
design
discovery
platform
enables
company
create
pipeline
product
candidates
using
immunomodulatory
effector
modules
ability
also
combine
effector
module
tether
module
bifunctional
format
pandion
lead
product
candidate
combination
mutein
effector
module
protein
backbone
designed
selectively
expand
regulatory
cells
systemically
without
activating
proinflammatory
cells
conventional
cells
natural
killer
cells
currently
phase
clinical
trial
pandion
continuing
develop
expand
library
effector
tether
modules
part
research
discovery
pipeline
information
please
visit
information
please
contact
media
kathryn
morris
yates
network
kathryn
investors
michelle
avery
pandion
therapeutics
investors
